Add to my selection

BESPONSA (inotuzumab ozogamicine)

Medicine - Posted on Oct 10 2022

Active substance (DCI)

inotuzumab ozogamicine

history (2)

9/21/22

BESPONSA (inotuzumab ozogamicine)

Key points Approval of reimbursement only for the treatment of adult patients with relapsed or refractory Philadelphia chrom...

CAV :
54321

icône flèche
2/7/18

BESPONSA (inotuzumab ozogamicin), antineoplastic monoclonal antibody

For the treatment of relapsed or refractory CD22 positive B-cell precursor acute lymphoblastic leukaemia, Philadelphia chrom...

CAV :
54321

icône flèche

Technical information

ATC code

L01XC26

Manufacturer

PFIZER PFE FRANCE

Presentation

BESPONSA 1 mg, poudre pour solution à diluer pour perfusion (code CIS : 61847017)
1 flacon(s) en verre brun de 1 mg - (Code CIP : 34009 550 334 7 9)

All our publications

Congenital, genetic and rare diseases

Hematologic cancers